Sure.
Thank you, Madam Chairperson, for the invitation to appear before the Standing Committee on Health to provide an overview and to answer questions about Bill C-6, the proposed Canada Consumer Product Safety Act.
My minister has asked me to convey to the committee her regrets. She has other obligations that prevent her from being able to appear before you today. I can assure you, however, that she's extremely committed to the passage of Bill C-6 and the benefits it would bring about for the health and safety of Canadians.
My name is Paul Glover and I am the Assistant Deputy Minister of the Healthy Environments and Consumer Safety Branch of Health Canada.
I am joined today by Charles Ethier, Director General of the Consumer Product Safety Directorate, by Robert Ianiro, Director of the Consumer Product Safety Bureau, and by Diane Labelle, General Counsel in charge of the legal services unit of Justice Canada that serves my branch.
Bill C-6 forms part of the government's comprehensive Food and Consumer Safety Action Plan.
As part of the action plan, Bill C-6 is intended to deal with consumer products, and will realize significant, tangible improvements in the health and safety of consumer products by focusing on three areas for improvement. The first is active prevention, to prevent problems before they occur. Second is targeted oversight, to ensure the system is working by providing us the information we need. Third is rapid response, the ability to act swiftly when required.
The act is based on the principles that industry has the primary responsibility for the safety of any product it manufactures, imports, or distributes to the Canadian public; that the public also has a responsibility for the maintenance of its health and the safe use of marketed products; and, finally, the government also has a role and responsibility to monitor and promote compliance and to enforce the legislation it administers.
The Government of Canada is committed to promoting and protecting the health and safety of Canadians, and the proposed act before you would be a significant tool that would enhance our ability at Health Canada.
I would like to take a moment to give you a brief example of how this act would fundamentally change our department's ability to take action when confronted with dangerous consumer products. I'd like to turn to a specific example.
You may recall from media reports that in 2006 there was a worldwide problem with small magnets in children's toys. In short, there was a line of toys that contained numerous, small, and very powerful magnets. A defect in the design of the toys resulted in the magnets being released from the toys. Unfortunately, numerous children ingested these magnets. These powerful magnets were drawn together in the stomachs and intestines of these children, which led to perforations, internal bleeding, and other internal problems.
Under the Hazardous Products Act, our 40-year-old consumer product safety legislation, the Government of Canada's ability to address this issue in a timely fashion was limited. In reality, the procedures we used with industry were voluntary.
Of course, the idea of working in partnership with industry is important, but when a voluntary approach does not produce the necessary results, the government must have the necessary authority to resolve the situation.
Without Bill C-6, we did not have the authority to order a recall, stop the sale of the product, or remove the product from store shelves.
Under the proposal before you, our ability to address this situation would be greatly improved. The toy manufacturer would have been required to submit health and safety incident reports when the problem emerged, thereby getting the department important information much earlier in the process. Thanks to the general prohibition in Bill C-6, there would have been various actions that we could have taken very quickly. We could have ordered a stop to the sale, manufacture, or importation of the product, and we could have had the product removed from store shelves.
In short, you can see how Bill C-6 would strengthen the department's ability to help promote and protect the health and safety of Canadians.
As was previously noted, the Hazardous Products Act has been around for 40 years, and it's been the legal instrument we've used for protecting the Canadian public from unsafe or dangerous consumer products. Although this product safety regime has served us well since coming into force in 1969, it has become outdated and is in need of modernization.
Today's marketplace is significantly more complex than that which existed in 1999. Globalization means that products sold in Canada now originate from all over the world. Changing technologies have introduced new materials and substances into the marketplace much more rapidly. And there are now more products available to Canadian consumers.
An exact count of the number of new products would be very difficult to give, but it is safe to say that there are millions of consumer products on the market in Canada, with thousands of new products introduced each year. This raises an interesting question about how Health Canada approaches product safety. While our department does have pre-market approval regimes in place for products such as pharmaceutical drugs and medical devices, the nature of the consumer product market means that the regulatory regime for consumer products covered by Bill C-6 is post-market.
This clearly underscores an importance of having the tools that are proposed under the act that would grant our ability to respond rapidly and take appropriate actions when dangerous consumer products appear.
Our major trading partners like the United States and the European Union have already modernized their product safety regimes to address new marketplace realities. This proposed act is in keeping with these safety regimes and would afford Canadians an equitable level of protection. It would also harmonize the requirements for industry.
Bill C-6 proposes a comprehensive suite of measures that respond to the need for a modern, efficient, and proactive product safety regime. At this time, I would like to give the committee a brief overview of some of the key features of the act.
The most significant change from the current legislation would be the introduction of a new general prohibition provision. The general prohibition would make it an offence for a supplier to manufacture, import, advertise, or sell a product that poses an unreasonable danger to the health or safety of the public. This provision both reinforces the fundamental responsibility of industry to ensure the safety of its products and gives the government the tools it needs to respond rapidly, if and when required.
If we look back at the example of the small magnet that I referred to at the beginning, the government prohibition would make enforcement options immediately available when there were no regulations in place in respect to the hazards posed by a particular product. This is in stark contrast to the Hazardous Products Act, where a product-by-product approach does not allow the enforcement action in respect of a production until a regulation is in place, which is often very time-consuming.
Bill C-6 would also introduce mandatory reporting. Manufacturers, importers, and others along the supply chain would be required by law to report any significant product-related health or safety incident or product defect within a set timeframe. Again, it's the notion of targeted oversight. Mandatory reporting would strengthen Health Canada's ability to quickly identify consumer product safety problems and to respond accordingly with appropriate corrective measures. Further, and significantly, it would contribute to our ability to make product safety information available to Canadians.
Inspector powers would be strengthened. Inspectors would have the authority to order suppliers to carry out recalls and other corrective measures when required. Bill C-6 would also permit inspectors to take action to follow through on the provision of a corrective measure when the supplier fails to do so.
To further support corrective measures, new document retention requirements would require suppliers to retain information about the source and distribution of their products. This would facilitate better information gathering and sharing in the case of a health and safety incident. I again turn to the small magnet. These provisions would have permitted the government to respond quickly and efficiently in applying corrective measures where most appropriate along the supply chain.
Where there is a well-founded suspicion of a health or safety concern of a particular product, authority would be given to the minister to require suppliers to test products or to provide results of tests or studies and other information that would allow the verification of compliance or prevent non-compliance with the act.
These requirements, as is the case with other provisions in the proposed act, would not introduce new, onerous requirements for industry. Rather, they are consistent with good business practice in the exercise of normal due diligence.
Bill C-6 would also raise fines and penalties to levels that are in line with other modern federal legislation and those of our trading partners.
I'd like to repeat: Bill C-6 would also raise fines and penalties to levels that are in line with other modern federal legislation and that of our trading partners.
As well, Bill C-6 would introduce an administrative monetary penalty scheme, which we refer to as AMPS, as a more flexible and responsible alternative to criminal prosecutions. The key provisions of the act would be complemented by a standard regulatory regime, which is in keeping with other pieces of modern legislation. The regulatory authority sought would enable the department to keep pace with technology in a marketplace that evolves almost daily. More importantly, it will enable the department to maintain the flexibility to take action when new consumer-product-related risks to health and safety present themselves.
In presenting the key elements of the act, I hope I have given you a sense of the main objectives of the proposed legislation and some new features that distinguish it from the existing act. I would also like to take this opportunity, before I conclude my remarks, to respond to concerns that we have heard that this proposal would be used to regulate natural health products.
It is not the government's intention to regulate natural health products though the consumer product legislation before you today. Natural health products are now, and will continue to be, regulated by the natural health products regulations under the Food and Drugs Act. The Minister of Health has written to you to inform this committee of the government's intention to propose an amendment to Bill C-6 to expressly communicate that natural health products are excluded.
In closing, I would like to reiterate that the proposed act would give the government the tools it needs to act swiftly and decisively to help protect Canadians from unsafe consumer products. My colleagues and I would now welcome the opportunity to answer any questions that you or the honourable colleagues may have.
Thank you, Madam Chairperson.